Cilcare raised €40 million in Series A funding led by SHIONOGI & CO., LTD. to advance clinical trials for its lead treatment CIL001 targeting cochlear synaptopathy.
Amount Raised
€40 Million
Round Type
Series A
MontpellierBiotechnologyHealth CareArtificial IntelligenceInvestors
Description
Cilcare has secured €40 million in Series A funding to kickstart two Phase 2a clinical trials in 2025 for its treatment CIL001, aimed at cochlear synaptopathy. The funding round saw contributions from new investors including SHIONOGI & CO., LTD., and existing investors such as Sofilaro and ARIS.
Quick answer
Cilcare raised €40 Million in a Series A round, dated December 6, 2024. Investors: Aris, Sofilaro, Shionogi & Co., Ltd., SudPME, Uvm Health Capital and Sprim Global Investments Pte, Ltd. Cilcare is based in Montpellier, Occitania, France.
- How much did Cilcare raise?
- Cilcare raised €40 Million in a Series A round on December 6, 2024.
- Who invested in Cilcare?
- Aris, Sofilaro, Shionogi & Co., Ltd., SudPME, Uvm Health Capital and Sprim Global Investments Pte, Ltd are named as investors in this round.
- What does Cilcare do?
- Cilcare is a biotechnology company specializing in auditory sciences, particularly focusing on developing therapies for cochlear synaptopathy, an underdiagnosed condition related to hearing loss.
- Where is Cilcare based and how big is it?
- Cilcare is based in Montpellier, Occitania, France. Fundz records about 46 employees.
- Who are the decision-makers at Cilcare?
- Fundz holds 2 contacts at Cilcare. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Cilcare that raised within 45 days of this round, from Fundz verified event records.
- Oxford Cancer Analytics raised $11M (Series A) on January 9, 2025.
- Pepticom raised $6.6M (Series A) on January 7, 2025.
- Grove AI raised $4.9M (Seed) on January 7, 2025.
- Carna raised $3.4M (Seed) on January 3, 2025.
- Concinnity Genetics raised $3.8M (Seed) on December 16, 2024.
- Vivid Mind raised $200K (Pre-Seed) on December 13, 2024.
Who to call at Cilcare, and when
A new round usually means Cilcare is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cilcare raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cilcare, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cilcare. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cilcare raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCilcare raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.